ImmunityBio Inc (IBRX)
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
📈 **POSITIVE** • High confidence analysis (86%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business